Although Nor Haryati has finished her treatment, doctors were loathe to say she was cancer-free due to the genetic mutation.

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.

Bianca Balti has left for Italy. The top model, who lives in the United States, posted a photo of herself on Instagram on a ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

A global study revealed that young breast cancer patients with high risk BRCA mutations can have their risk of cancer recurrence reduced significantly by undergoing mastectomy and/or ovary removal, of ...

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

New data shows that over 25,000 free saliva test kits have now been requested and delivered as part of the NHS Jewish BRCA Testing Programme since its launch in January 2023. Around 11,000 tests have ...

Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard ...

【导读】帕博西尼（Palbociclib）是一种CDK4/6抑制剂，在治疗HR+乳腺癌中发挥着至关重要的作用。然而，palbociclib的耐药性是一个值得进一步研究的重大问题。团队的研究发现，TMEM45A是palbociclib耐药性的潜在驱动因 ...

The screening programme looks for mutations in the BRCA genes which push up a person’s risk of cancer. Everyone has BRCA1 and BRCA2 genes, but people who have changes in the gene are at higher ...